The purpose of this review is to summarize the recent evidence on the distinct atopic phenotypes and their relationship with childhood asthma. We start by considering definitions and phenotypic classification of atopy and then review evidence on its association with asthma in children.
INTRODUCTION
Asthma is a complex disease characterized by a number of features, including inflammation in the airways. This inflammation can be triggered by allergens (in atopic asthma) or nonallergic irritants (in nonatopic asthma), but in most patients, both allergic and nonallergic factors contribute to the clinical presentation of the disease. Although allergic sensitization is a strong risk factor for asthma [1] , not all asthma is allergic in nature, and most sensitized individuals do not develop asthma or other allergic diseases [2, 3] . This complex interplay between allergic sensitization and asthma, and a series of phenotyping studies that discriminated distinct sub-types of asthma [4,5 && ], eczema [6 & ] and atopy [7] [8] [9] 10 & -12 & , 13, 14] , have provided support to the concept of heterogeneity of asthma and allergic sensitization.
HETEROGENEITY OF ASTHMA
It is now accepted that asthma is a heterogeneous condition constituting multiple subgroups and aetiological factors, and that it should be deconstructed into traits [15 && ]. Recognition of this heterogeneity has led researchers away from a focus on a single biological marker or clinical test that may be applicable to all patients with asthma, towards more personalized approaches that can address specific challenges in individual patients, or groups of patients. Over the last two decades, a substantial effort has been devoted to understanding asthma heterogeneity, and its variable clinical expression in individuals [15 && ,16,17] . One approach to understanding disease heterogeneity involves integrating a series of statistical models that account for the unobserved heterogeneity between individuals, with mechanistic information about underlying pathophysiology [18 & ]. For example, the latent class analysis relies on the assumption that observable characteristics are imperfect indicators of an underlying (latent) construct [19] . Over the last two decades, many attempts have been made to identify longitudinal trajectories of childhood wheeze [4, [20] [21] [22] [23] [24] [27] [28] [29] by means of latent class analysis. Such 'phenotyping' studies have traditionally been based on clinical characteristics that are mostly observed and recorded by physicians in the clinical/research settings. However, features, which are collected to ascertain asthma presence or severity may not be the most informative for the discovery of true disease endotypes. A recent study has shown that a careful synergy of data-driven methods and clinical interpretation may help better understand the heterogeneity of asthma, and enable the discovery of true asthma endotypes [5 && ]. This study has identified allergic sensitization as one of the four potentially important features for disaggregating childhood asthma, the other three being the age of onset, asthma severity and recent exacerbations.
One key conclusion is that computational approaches can aid the interpretation of clinical and healthcare data by identifying disease subgroups, and their relationship to particular risk factors. However, in the absence of mechanistic information on underlying pathophysiology, it is difficult to identify whether or which of these sub-groups are clinically relevant. Understanding biological mechanism underpinnings of different asthma endotypes, and the effects of genetic and environmental factors, is of critical importance to untangle the underlying pathophysiology, and is a key step to advance personalized (or stratified) medicine in asthma [30] . However, to date, the identification of asthma subgroups described in different studies, and how the current approach to 'asthma phenotyping' may lead to more effective and targeted asthma treatment strategies, has not been translated to clinical setting [ 
HETEROGENEITY OF ALLERGIC SENSITIZATION AND ITS RELEVANCE TO ASTHMA
Atopy can be defined as the genetic tendency to become sensitized to common allergens that most people do not react to, as a result of ordinary exposure. Atopic diseases cover a heterogeneous group of symptoms and disorders, ranging from wheezing, coughing, breathlessness, hay fever and rhinitis, to skin conditions such as atopic dermatitis (eczema, or atopic eczema), each of which might be triggered by different factors. Different manifestations of atopic disease may co-exist in the same patient, or develop at different times [32] . However, a history of atopy and confirmation of IgE-mediated sensitization (e.g. using skin prick tests and/or measurement of specific serum IgE) does not necessarily indicate the presence of an immunologically mediated allergic reaction and/or allergic disease, as sensitization may be asymptomatic [3] . Recent evidence has shown that similar to asthma, 'atopic sensitization' is heterogeneous, and that there are several distinct sub-groups of sensitization, differing in their risk factors, associations with asthma progression and response to treatment [8, 9, 13, 14, 33, 34, 35 
The disaggregation of sensitization, and knowing which subtype a child belongs to, may help predict how the allergic disease is likely to progress, and later-life asthma outcomes.
Patterns of sensitization were first investigated by Kurukulaaratchy et al. [7] , who proposed an investigator-defined phenotypical classification of childhood atopy based on the timing of development of sensitization to common allergens (early childhood atopy, chronic childhood atopy and delayed childhood atopy). In an attempt to move from dichotomous (positive or negative, atopic or nonatopic) and opinion-based classifiers, to datedriven classification of allergic sensitization, we applied machine-learning techniques to skin test and IgE data collected on multiple time points throughout childhood in a population-based birth cohort [8] . We uncovered four different classes of sensitization, including predominantly dust mite, nondust mite, multiple early and multiple late sensitization, and have shown distinct associations of these classes with asthma. We have subsequently replicated these findings in another birth cohort [9] , and have demonstrated that the association with
KEY POINTS
To increase the diagnostic accuracy of current allergy tests (skin tests and IgE to whole allergen extracts) in relation to the presence and persistence of asthma, the results should be interpreted in a quantitative manner by using the titre of IgE, or the size of skin test wheal diameter; furthermore, age and sex of the patient should be taken into account.
We urgently need better diagnostic markers and algorithms to help practicing physicians differentiate between benign and clinically important allergic sensitization.
Existing asthma risk prediction tools are not well suited for clinical use; forthcoming algorithms for the diagnosis and prognosis of asthma may include novel ways of assessing IgE sensitization status.
asthma and diminished lung function is strong for multiple early, but not other sensitization classes [37] . In another study, Garden et al. [14] described three latent atopic phenotypes using longitudinal data on skin prick sensitivity (late mixed inhalant sensitization, mixed food and inhalant sensitization, and dust mite monosensitization). Havstad et al. [34] classified sensitized children at 2 years of age into three latent atopic sensitization classes based on allergen-specific IgE patterns (highly sensitized, milk and egg-dominated sensitization, and peanut and inhalant/no milk sensitization). Stoltz et al. [13] analysed patterns of allergen-specific sensitization based on the patterns of pet exposure, the presence of specific aeroallergen sensitization and its quantitative degree, and described numerous different sensitization patterns (any sensitization; mono-sensitization; poly-sensitization; cat; dog; dust-mite; Alternaria spp.; cockroach; ragweed; birch and grass). In another study [10 & ], atopic sensitization was classified into three phenotypes (benign atopy, symptomatic atopy and severe atopy). More recently, Dharma et al. [38] revealed four distinct patterns of allergic sensitization (atopic dermatitis; inhalant sensitization; transient sensitization and persistent sensitization).
Our finding that the timing of onset and types of sensitization are the key discriminative factor for atopy subtypes [8, 9, 33] has been independently confirmed by a recent study [11 & ], which reported the existence of four distinct atopy phenotypes, differing in the time of onset and types of sensitizing allergens (later sensitization to indoor allergens, multiple early sensitization, early sensitization to outdoor allergens followed by indoor allergens, and early sensitization to indoor allergens followed by outdoor allergens). Similarly, Schoos et al. [12 & ] explored the longitudinal patterns of atopic sensitization in early childhood based on sIgE responses and revealed a total of seven latent sensitization patterns: cat/dog/horse; timothy grass/birch; molds; house dust mites; peanut/wheat flour/mugwort; peanut/soybean and egg/milk/ wheat flour. Although direct comparison between studies is difficult because of differences in subject ascertainment, population structure and diagnostic criteria, there is increasing evidence that the risk of asthma is significantly higher among children who are highly sensitized [10 & ,34] , sensitized early in life [8, 9, 33] , or sensitized to multiple allergens [9, 14] . Additionally, sensitization to allergens from specific sources as dogs [13] , cats or horses [12 & ] was reported to be strongly associated with asthma development during childhood. Summary of cross-sectional and longitudinal studies in children, which employed investigator-led and data-driven approaches to identify distinct patterns of allergic sensitization, and their specific relationship with asthma, is shown in Table 1 .
The number and type of 'sensitization phenotypes' is driven by the nature of the data; however, although different sensitization classes can be uncovered using a large amount of data collected over long periods of time, this cannot be directly translated to a clinical situation, whenever a practicing physician sees a child at any one time point. We urgently need better diagnostic markers and algorithms to help practicing physicians differentiate between benign and clinically important allergic sensitization.
DIAGNOSTIC TESTS TO ASCERTAIN ALLERGIC SENSITIZATION AND ITS RELATION TO ASTHMA
Skin tests and blood tests are commonly used to diagnose clinical allergies and sensitivities. However, in the context of respiratory allergy, the interpretation of these commonly used allergy tests remains arbitrary, as it traditionally relies on predefined cut-offs that have relatively poor ability to distinguish between asymptomatic sensitizations and clinically relevant allergies, and does not take into account either age, sex or ethnicity of the patient. A recent study has demonstrated that both age and sex should be taken into account whenever interpreting the results of skin tests and sIgE measurement, and that age-specific and sex-specific normative data are urgently needed [39 && ]. To increase the diagnostic accuracy of current allergy tests in relation to the presence and persistence of asthma, the results should be reported in a quantitative manner (e.g. the titre of IgE, or the size of skin test wheal diameter). There is a clear need to develop better ways of interpreting these tests to identify patients with clinically relevant allergies more precisely, for example, by taking into consideration sex, age and environmental exposure.
There is increasing evidence that sensitization to some, but not all allergenic proteins from different sources is important for the expression and severity of asthma, and that assessing sensitization to specific allergen components using componentresolved diagnostics (CRD) may be more informative than standard tests using whole allergen extracts. We have shown that patterns of IgE responses to multiple allergenic molecules have reasonable discrimination ability for childhood asthma and rhinoconjuinctivitis [40] . In a recent publication, IgE reactivity to a limited number of allergen molecules early in life identified children with a high risk of both asthma and rhinitis in adolescence ]. In a study using latent variable modelling, we identified three crosssectional clusters of IgE responses to multiple allergens from different protein families in mid-school age, and each of these patterns was associated with different magnitude of risk for having allergic airway symptoms [41] . Our subsequent study has indicated that longitudinal trajectories of sensitization patterns to a limited number of grass and dust mite allergens from age 5 to age 11 years had different associations with clinical outcomes, indicating that the time of onset of specific patterns of IgE response may be critically important [33] . Similarly, Posa et al. [42 && ] have recently shown that IgE polysensitization to several dust mite molecules predicts current rhinitis, and both current and future asthma. These data indicate that understanding the structure in the developmental pathways of IgE responses to multiple allergenic molecules may facilitate development of better diagnostic and prognostic algorithms for asthma. To address this, we have recently described the architecture of the evolution of IgE responses to more than 100 allergen components from infancy to adolescence [35 && ]. By applying novel machine-learning techniques to CRD sensitization data throughout childhood, we identified latent structure in the diversification of IgE responses (Fig. 1) , and have shown that the timing of onset of specific patterns of sensitization may be CAPS, childhood asthma prevention study; CHEER, children's health and environmental research; CHILD, Canadian healthy infant longitudinal development; COAST, childhood origins of asthma; COPSAC, Copenhagen prospective studies on asthma in childhood; IOW, Isle of wight; MAAS, Manchester asthma and allergy study; MAS, multizentrische allergiestudie; PASTURE, protection against allergy: study in rural environments; sIgE, specific IgE; SPT, skin prick test; WHEALS, Wayne County health, environment, allergy and asthma longitudinal study.
one of the important indicators of the subsequent risk of asthma and rhinitis [35 && ]. Furthermore, the results of this study suggest that the latent structure of IgE allergenic component clusters is a reflection of the source of allergens, the function of allergenic molecules, and a marker of the pathophysiological processes leading to the development of distinct clinical presentations. Better resolution of longitudinal patterns of sensitization to multiple individual allergenic molecules may facilitate the development of diagnostic algorithms, which can be used for the prediction of current and future risk. However, the number and type of specific components, which are relevant in different geographical areas, at different ages, and for different allergic diseases, remains to be determined.
DIAGNOSTIC AND PROGNOSTIC TEST FOR ASTHMA
Difficulties related to confirming the diagnosis of allergy is only a small part of a bigger diagnostic problem in asthma. Figure 2 shows diagnostic aids for asthma in children and specific difficulties associated with each step. The UK National Institute of Health and Care Excellence (NICE) guidance on the diagnosis of asthma using objective tests does not recommend assessment of sensitization as an objective test for asthma diagnosis. Rather, the NICE interim report proposes a diagnostic algorithm, which incorporates the sequential use of four measures of lung function and inflammation in children with suggestive symptoms (spirometry, bronchodilator reversibility, fractional exhaled nitric oxide and peak flow variability; http://www.ngc.ac.uk/ Guidelines/In-Development/). We have recently tested the proposed algorithm amongst children aged 13-16 years, and found poor agreement between the algorithm and asthma defined by physician diagnosis, presence of current symptoms and regular use of inhaled corticosteroids [43 & ]. These findings suggest that the proposed NICE algorithm for diagnosing asthma should not be implemented in children until better evidence is available.
The ability to predict individuals who may become asthmatic in the long-term is equally FIGURE 1. Clustering IgE components from infancy (age 1 year) to adolescence (age 16 years) in a population-based birth cohort study. Adapted with permission from [35] . Cluster membership was determined using a Bernoulli Mixture Model applied to binarized sensitization data from all individuals.
Development of allergic sensitization and asthma Oksel and Custovic important to prevent asthma, or minimize its impacts on many aspects of the lives of individuals. There has been a significant amount of work carried out on developing predictive models that could be incorporated into the decision-making process [44] [45] [46] [47] [48] , which has been systematically reviewed and critically evaluated recently [49, 50] . Although the majority of existing asthma prediction models were developed based on either clinical indices or regression equations [50] , there is an increasing trend towards using machine-learning approaches to develop predictive models for asthma [51, 52] . However, in the absence of standardized asthma outcome definitions, diagnostic criteria for asthma and independent validation studies in different cohorts, the clinical value of the developed predictive models, and their applicability to other populations and different healthcare settings, remains unclear. Moreover, the predictive accuracy of asthma predictive indices and models decreases with the increasing prevalence of asthma in the population studied [53] , suggesting that, although these tools may be useful in low-risk populations, their prediction performance is still far from being satisfactory in clinical settings, especially for highrisk patients. Overall, existing asthma risk prediction tools are not well suited for clinical use in their current form, and need to be validated in different populations before their successful utilization in daily medical practice and decision-making.
One of the key questions going forward is how best to incorporate tests for the assessment of allergic sensitization into diagnostic algorithms for asthma, both in terms of confirming asthma diagnosis, and the assessment of future risk (e.g. of asthma exacerbations, or disease persistence). It is possible that such diagnostic algorithms may include not only the measurement of allergenspecific IgE but also allergen-specific IgG responses. In three birth cohort studies, we have shown that dissociation between allergic airway symptoms and sIgE sensitization in children is associated with a high-level coproduction of sIgG 1 [54 && ]. A consistent feature of children who were moderately or highly sensitized to inhalant allergens, but who did not have allergic airway disease (asthma or rhinitis), as compared with equally sensitized but symptomatic children, was an increased aeroallergen-specific IgG/ IgE antibody ratio [54 && ]. This association was strong and reproducible for sensitization-associated risk for both asthma and rhinitis (in relation to sensitization against dust mite and grass, respectively). Furthermore, we observed a similar relationship for asthma severity, and the risk of asthma exacerbations. These findings of a sharp inverse relationship between dust mite-specific IgG 1 /IgE ratios to the presence, persistence and severity of childhood wheezing and asthma, and of a similar inverse relationship between hay fever and grass-specific IgG 1 /IgE ratios, suggest that sIgG1/sIgE ratio may be a potentially readily available biomarker for the assessment of allergic airway diseases in childhood.
Taken together, the studies, which we reviewed suggest that it may be possible to develop individualized risk prediction algorithms for the diagnosis and prognosis of asthma, which should include novel methods for assessing IgE sensitization status, likely in conjunction with a limited information on the patterns and severity of symptoms, and other objective tests (e.g. lung function and measurement of airway inflammation).
CONCLUSION
Novel computational approaches can aid disaggregation of complex phenotypes such as asthma and allergic sensitization, but in the absence of mechanistic knowledge, it is difficult to identify whether or which of the discovered sub-groups are clinically relevant. The disaggregation of allergic sensitization, and knowing which subtype a child belongs to, may help predict how the allergic disease is likely to progress, and later-life asthma outcomes. One of the important questions going forward is how best to incorporate tests for the assessment of allergic sensitization into diagnostic algorithms for asthma, both in terms of confirming asthma diagnosis, and the assessment of future risk. This study highlights the importance of cross-disciplinary research and integrative approaches, whereby basic scientists, clinicians, data analysts and epidemiologists work together to understand the heterogeneity of asthma.
